Initial Workup and Management of Hiccups
For patients presenting with hiccups, the initial workup should focus on identifying underlying causes while chlorpromazine (25-50 mg orally three to four times daily) is the first-line pharmacological treatment for persistent cases.
Classification and Initial Assessment
Hiccups (singultus) can be categorized based on duration:
- Acute hiccups: Less than 48 hours
- Persistent hiccups: 48 hours to 2 months
- Intractable hiccups: More than 2 months
Key Elements in History Taking
- Duration and pattern of hiccups
- Aggravating and relieving factors
- Associated symptoms (reflux, abdominal pain, neurological symptoms)
- Medication review (steroids, anti-parkinsonian drugs, anesthetics)
- Recent procedures or instrumentation
- Alcohol consumption
Physical Examination Focus Points
- Vital signs
- Abdominal examination for distension or organomegaly
- Neurological examination (cranial nerves, focal deficits)
- Ear examination (foreign bodies, infection)
- Chest and cardiac examination
Diagnostic Workup
For acute, self-limited hiccups with no concerning features, extensive workup is usually unnecessary. For persistent or intractable hiccups, consider:
First-line investigations:
- Complete blood count
- Comprehensive metabolic panel
- Chest X-ray
- ECG
Second-line investigations (based on clinical suspicion):
- CT scan of chest/abdomen (if diaphragmatic irritation suspected) 1
- Brain imaging (if neurological symptoms present)
- Upper endoscopy (if GERD or gastric distension suspected)
- Echocardiogram (if cardiac cause suspected)
Management Algorithm
1. Acute Hiccups (< 48 hours)
- Physical maneuvers (first attempt):
- Stimulation of uvula or pharynx
- Breath holding or breathing into paper bag
- Drinking water from the opposite side of a glass
- Physical counterpressure maneuvers (PCMs) such as leg crossing or hand grip
2. Persistent Hiccups (48 hours - 2 months)
- Treat underlying cause if identified
- First-line pharmacotherapy: Chlorpromazine 25-50 mg orally three to four times daily 2, 3
3. Intractable Hiccups (> 2 months)
- Multidisciplinary approach involving gastroenterology, neurology, and possibly psychiatry
- Consider additional pharmacotherapy:
- Baclofen
- Gabapentin
- Metoclopramide
- Proton pump inhibitors (if GERD-related)
Common Causes and Targeted Management
Gastrointestinal Causes
- GERD: PPI therapy (most common cause of persistent hiccups) 5
- Gastric distension: Nasogastric decompression if severe
- Hepatomegaly: Address underlying liver disease
Central Nervous System Causes
- Stroke: Neurological consultation and appropriate management
- Space-occupying lesions: Neurosurgical consultation if appropriate
- Multiple sclerosis: Disease-modifying therapy
Metabolic/Toxic Causes
- Alcohol: Supportive care, abstinence
- Uremia: Dialysis if indicated
- Electrolyte imbalances: Correction of abnormalities
Important Caveats
- Don't rely solely on physical maneuvers for persistent hiccups; they rarely provide lasting relief in cases with underlying pathology 3
- Don't delay pharmacotherapy when hiccups are causing significant distress or interfering with eating, sleeping, or breathing
- Avoid excessive sedation in elderly patients when using chlorpromazine; start with lower doses (10-25 mg) 2
- Monitor for QT prolongation with chlorpromazine, especially if combining with other QT-prolonging medications 6
- Consider GERD as a common underlying cause even without typical reflux symptoms 5
Special Populations
Elderly Patients
- Use lower doses of chlorpromazine (10-25 mg) 2
- Monitor closely for hypotension and extrapyramidal side effects
- Consider drug interactions with existing medications
Pediatric Patients
- Chlorpromazine dosing: 0.25 mg/lb body weight every 4-6 hours as needed 2
- Maximum daily dose varies by age:
- 6 months to 5 years (or up to 50 lbs): not over 40 mg/day
- 5-12 years (or 50-100 lbs): not over 75 mg/day except in severe cases
By following this systematic approach to evaluation and management, most cases of hiccups can be effectively treated while identifying any serious underlying conditions.